Mycophenolate Mofetil in Myasthenia Gravis

Summary

This is a prospective, multi-center, double-blind, placebo-controlled trial to determine the efficacy and safety of mycophenolate mofetil (MM) in combination with prednisone as the initial form of immunosuppression in patients with acquired myasthenia gravis (MG).

Timeline

Start

2002-09

Primary completion

—

Completion

2007-03

Drugs

Indications